Talk:Dalbavancin
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Dalbavancin.
|
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
clinical trial details and results
editArticle could use references to clinical trial details and results. - Rod57 (talk) 12:28, 10 May 2011 (UTC)
It also neglects to mention that most MRSA strains are susceptible to common antibiotics such as tmp-smx, doxycycline and clindamycin. — Preceding unsigned comment added by 69.4.130.98 (talk) 18:27, 2 September 2015 (UTC)
Trial
editNon-inferior to vancomycin +/- linezolid. doi:10.1056/NEJMoa1310480 JFW | T@lk 14:16, 9 June 2014 (UTC)
Dalbavancin is a mixture of 5 different molecules
editThe chemical and physical data and the chemical structure suggest that Dalbavancin is one defined molecule. However, as per the EMA public assessment report it is a mixture of five molecules: Dalbavancin A0 and A1, Dalbavancin B0, B1 and B2. They differ from one another primarily in the length and/or branching of their respective fatty acid side chains. See page 10 [1]
What do I use for it to tack rash away
editNeed to take rash away 2600:1012:B10A:68BE:411:73F:FFCA:2AC6 (talk) 05:29, 15 April 2024 (UTC)
- It's been three day and it getting worse 2600:1012:B10A:68BE:411:73F:FFCA:2AC6 (talk) 05:30, 15 April 2024 (UTC)